Healthcare >> CEO Interviews >> May 29, 2000
L. WILLIAM MCINTOSH has served as President and Chief Operating Officer
of Nexell Therapeutics since March 1, 1998. From May 1997 through
February 1998, he served as Senior Vice President of Business
Development and Finance and Chief Financial Officer of the c ompany.
Prior to joining Nexell, Mr. McIntosh served as Senior Vice President of
Business Development and Commercial Operations for Zynaxis Inc., a
biotechnology company with both drug delivery and diagnostic
technologies. Mr. McIntosh has served in senior management positions at
SmithKline Beecham (as a full-time consultant), Boehringer Mannheim
Pharmaceuticals Corporation, Medco Containment Services, Inc., and Merck
and Co., Inc. He currently serves of the Board of Directors of VIRxSYS
Corporation. Mr. McIntosh earned a BS in Business Administration and an
MBA from Lehigh University. Profile
Therapeutics?
Mr. McIntosh: Nexell Therapeutics is the leading developer and marketer
of innovative ex vivo cell therapies and
